Cargando…
Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene
Understanding the biological pathways critical for common neurofibromatosis type 1 (NF1) peripheral nerve tumours is essential, as there is a lack of tumour biomarkers, prognostic factors and therapeutics. We used gene expression profiling to define transcriptional changes between primary normal Sch...
Autores principales: | Miller, Shyra J, Jessen, Walter J, Mehta, Tapan, Hardiman, Atira, Sites, Emily, Kaiser, Sergio, Jegga, Anil G, Li, Hua, Upadhyaya, Meena, Giovannini, Marco, Muir, David, Wallace, Margaret R, Lopez, Eva, Serra, Eduard, Nielsen, G Petur, Lazaro, Conxi, Stemmer-Rachamimov, Anat, Page, Grier, Aronow, Bruce J, Ratner, Nancy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378132/ https://www.ncbi.nlm.nih.gov/pubmed/20049725 http://dx.doi.org/10.1002/emmm.200900027 |
Ejemplares similares
-
An update on the CNS manifestations of neurofibromatosis type 2
por: Coy, Shannon, et al.
Publicado: (2019) -
Correction to: An update on the CNS manifestations of neurofibromatosis type 2
por: Coy, Shannon, et al.
Publicado: (2019) -
Neurofibromatosis 2011: a report of the Children’s Tumor Foundation Annual Meeting
por: Kalamarides, Michel, et al.
Publicado: (2011) -
Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas
por: Kukutla, Phanidhar, et al.
Publicado: (2021) -
Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2
por: Prabhakar, Shilpa, et al.
Publicado: (2022)